SlideShare a Scribd company logo
1 of 2
ward pharmacist economical assessement and actions
ASHP Guidelines:clinical pharmacy service,in which pharmacist provide direct patient care are
important foundation for succesful medication utilization management program focused on
managing drug cost
tools and approach
Health economics, pharmacoeconomy, healthcare management resource with rational
allocation
cost analisys -cost- benefit, cost efficacy, cost effectiveness ( anayitical way, cost center )
appropriateness
regulatory ( central reimbursement classification, limitation note etc )
management budget control
systematic approach
prioritizing management startegies
drug budgeting( formulary/non formulary)
budget impact analisys
cost containment targets definied
medication cost management project selection ( ex. high expensive or high budget impact
therapy )
benchmarking
data analysis
formulary management,drug restriction policy
dose unit systems ( ex. to reduce waste), ICT
collaborative working group ( team , central pharmacy , hospital management)
ward clinical pharmacy service,clinical pharmacist with advanced training dedicated to cost
management project
monitoring
buying strategy
use of Evidence based criteria, biomedical literature use
generic drug intensive use
drug day ( ex to reduce waste )
iv os switch ( to reduce cost )
iv waste reduction
comunication skills
comitee partecipation ( departmental)
updating

More Related Content

What's hot

Banner Health
Banner HealthBanner Health
Banner Healthlponssa
 
Encouraging best practice and improve the rational use of medicines
Encouraging best practice and improve the rational  use of medicinesEncouraging best practice and improve the rational  use of medicines
Encouraging best practice and improve the rational use of medicinesMeTApresents
 
Penultimate revised version of the bia guidelines capt-poster presentation-2019
Penultimate revised version of the bia guidelines capt-poster presentation-2019Penultimate revised version of the bia guidelines capt-poster presentation-2019
Penultimate revised version of the bia guidelines capt-poster presentation-2019Naghmeh Foroutan
 
Cadth 2015 c6 panel collab formulary hospital-public plan - eric lun final
Cadth 2015 c6 panel   collab formulary hospital-public plan - eric lun finalCadth 2015 c6 panel   collab formulary hospital-public plan - eric lun final
Cadth 2015 c6 panel collab formulary hospital-public plan - eric lun finalCADTH Symposium
 
Overview of Quantification
Overview of QuantificationOverview of Quantification
Overview of QuantificationDr. Kabiru Gulma
 
3 the budget – pre paration and imple mentation
3 the budget – pre paration and imple mentation3 the budget – pre paration and imple mentation
3 the budget – pre paration and imple mentationChanukya Vanam . Dr
 
Therapeutic cost management- Lou Sandoval Hippocratic Health Solutions
Therapeutic cost management- Lou Sandoval Hippocratic Health SolutionsTherapeutic cost management- Lou Sandoval Hippocratic Health Solutions
Therapeutic cost management- Lou Sandoval Hippocratic Health SolutionsLou Sandoval
 
Biosimilars for Rheumatoid Arthritis
Biosimilars for Rheumatoid Arthritis Biosimilars for Rheumatoid Arthritis
Biosimilars for Rheumatoid Arthritis Covance
 
Multi-Indication Pricing: Do we want it? Can we operationalize it?
Multi-Indication Pricing: Do we want it? Can we operationalize it?Multi-Indication Pricing: Do we want it? Can we operationalize it?
Multi-Indication Pricing: Do we want it? Can we operationalize it?Office of Health Economics
 
The Gemini Generic HIS
The Gemini Generic HISThe Gemini Generic HIS
The Gemini Generic HISThe Gemini
 
pharmacy practice and scope in Ethiopia: An over view
pharmacy practice and scope in Ethiopia: An over viewpharmacy practice and scope in Ethiopia: An over view
pharmacy practice and scope in Ethiopia: An over viewMohammed Mohammed
 
Pharmacy: Criterion audit
Pharmacy: Criterion auditPharmacy: Criterion audit
Pharmacy: Criterion auditNES
 
CROs Must Embrace Digital Education Systems
CROs Must Embrace Digital Education SystemsCROs Must Embrace Digital Education Systems
CROs Must Embrace Digital Education SystemsJim Cucinotta
 
Data Governance for Real-World Evidence: Cross-country differences and recomm...
Data Governance for Real-World Evidence: Cross-country differences and recomm...Data Governance for Real-World Evidence: Cross-country differences and recomm...
Data Governance for Real-World Evidence: Cross-country differences and recomm...Office of Health Economics
 
“Multi-indication Pricing: Do we want it? Can we operationalize it?”
“Multi-indication Pricing: Do we want it? Can we operationalize it?”“Multi-indication Pricing: Do we want it? Can we operationalize it?”
“Multi-indication Pricing: Do we want it? Can we operationalize it?”Office of Health Economics
 

What's hot (20)

Banner Health
Banner HealthBanner Health
Banner Health
 
Encouraging best practice and improve the rational use of medicines
Encouraging best practice and improve the rational  use of medicinesEncouraging best practice and improve the rational  use of medicines
Encouraging best practice and improve the rational use of medicines
 
Pharmaceutical care clinical and economical results 2014 N.48
Pharmaceutical care clinical and  economical results 2014 N.48Pharmaceutical care clinical and  economical results 2014 N.48
Pharmaceutical care clinical and economical results 2014 N.48
 
Situated change
Situated changeSituated change
Situated change
 
Penultimate revised version of the bia guidelines capt-poster presentation-2019
Penultimate revised version of the bia guidelines capt-poster presentation-2019Penultimate revised version of the bia guidelines capt-poster presentation-2019
Penultimate revised version of the bia guidelines capt-poster presentation-2019
 
Cadth 2015 c6 panel collab formulary hospital-public plan - eric lun final
Cadth 2015 c6 panel   collab formulary hospital-public plan - eric lun finalCadth 2015 c6 panel   collab formulary hospital-public plan - eric lun final
Cadth 2015 c6 panel collab formulary hospital-public plan - eric lun final
 
Overview of Quantification
Overview of QuantificationOverview of Quantification
Overview of Quantification
 
3 the budget – pre paration and imple mentation
3 the budget – pre paration and imple mentation3 the budget – pre paration and imple mentation
3 the budget – pre paration and imple mentation
 
Therapeutic cost management- Lou Sandoval Hippocratic Health Solutions
Therapeutic cost management- Lou Sandoval Hippocratic Health SolutionsTherapeutic cost management- Lou Sandoval Hippocratic Health Solutions
Therapeutic cost management- Lou Sandoval Hippocratic Health Solutions
 
Patient Flow Composite Score for a Childrens Hospital 4 21 11
Patient Flow Composite Score for a Childrens Hospital 4 21 11Patient Flow Composite Score for a Childrens Hospital 4 21 11
Patient Flow Composite Score for a Childrens Hospital 4 21 11
 
Biosimilars for Rheumatoid Arthritis
Biosimilars for Rheumatoid Arthritis Biosimilars for Rheumatoid Arthritis
Biosimilars for Rheumatoid Arthritis
 
Multi-Indication Pricing: Do we want it? Can we operationalize it?
Multi-Indication Pricing: Do we want it? Can we operationalize it?Multi-Indication Pricing: Do we want it? Can we operationalize it?
Multi-Indication Pricing: Do we want it? Can we operationalize it?
 
The Gemini Generic HIS
The Gemini Generic HISThe Gemini Generic HIS
The Gemini Generic HIS
 
pharmacy practice and scope in Ethiopia: An over view
pharmacy practice and scope in Ethiopia: An over viewpharmacy practice and scope in Ethiopia: An over view
pharmacy practice and scope in Ethiopia: An over view
 
Pharmacy: Criterion audit
Pharmacy: Criterion auditPharmacy: Criterion audit
Pharmacy: Criterion audit
 
CROs Must Embrace Digital Education Systems
CROs Must Embrace Digital Education SystemsCROs Must Embrace Digital Education Systems
CROs Must Embrace Digital Education Systems
 
Data Governance for Real-World Evidence: Cross-country differences and recomm...
Data Governance for Real-World Evidence: Cross-country differences and recomm...Data Governance for Real-World Evidence: Cross-country differences and recomm...
Data Governance for Real-World Evidence: Cross-country differences and recomm...
 
MoCA
MoCAMoCA
MoCA
 
“Multi-indication Pricing: Do we want it? Can we operationalize it?”
“Multi-indication Pricing: Do we want it? Can we operationalize it?”“Multi-indication Pricing: Do we want it? Can we operationalize it?”
“Multi-indication Pricing: Do we want it? Can we operationalize it?”
 
ISPOR poster ri lwcp 140515
ISPOR poster   ri lwcp  140515ISPOR poster   ri lwcp  140515
ISPOR poster ri lwcp 140515
 

Similar to Ward pharmacist economical assessment and actions, management tools , innovative technologies ,dose unit systems , pharmaceutical care , clinical pharmacy 2016 n.52 m .luisetto

Pharmacoeconomics5-WPS Office.pdf
Pharmacoeconomics5-WPS Office.pdfPharmacoeconomics5-WPS Office.pdf
Pharmacoeconomics5-WPS Office.pdfSudipta Roy
 
Pharmacoeconomics pptx
Pharmacoeconomics pptxPharmacoeconomics pptx
Pharmacoeconomics pptxVishwasATL
 
Luisetto m logistics ict systems and clinical pharmaceutical care strategies...
Luisetto m  logistics ict systems and clinical pharmaceutical care strategies...Luisetto m  logistics ict systems and clinical pharmaceutical care strategies...
Luisetto m logistics ict systems and clinical pharmaceutical care strategies...M. Luisetto Pharm.D.Spec. Pharmacology
 
Cost cutting in hospitals
Cost cutting in hospitalsCost cutting in hospitals
Cost cutting in hospitalsJosep Arroyo
 
PMY 6110_1-6-Pharmaceutical Care Evaluation.pdf
PMY 6110_1-6-Pharmaceutical Care Evaluation.pdfPMY 6110_1-6-Pharmaceutical Care Evaluation.pdf
PMY 6110_1-6-Pharmaceutical Care Evaluation.pdfMuungoLungwani
 
Health products and technologies Dr. Julius Ogato, Ministry of Health. Head...
Health products and technologies   Dr. Julius Ogato, Ministry of Health. Head...Health products and technologies   Dr. Julius Ogato, Ministry of Health. Head...
Health products and technologies Dr. Julius Ogato, Ministry of Health. Head...Emmanuel Mosoti Machani
 
Research article a new #management healthcare systems to efficiently reduce h...
Research article a new #management healthcare systems to efficiently reduce h...Research article a new #management healthcare systems to efficiently reduce h...
Research article a new #management healthcare systems to efficiently reduce h...M. Luisetto Pharm.D.Spec. Pharmacology
 
ASHP Standard for pharmacy supportive personnel
ASHP Standard for pharmacy supportive personnelASHP Standard for pharmacy supportive personnel
ASHP Standard for pharmacy supportive personnelRiyaDas765755
 
Study of Drug Expenditure at RMMCH 24 Hours Pharmacy - ABC VED Analysis
Study of Drug Expenditure at RMMCH 24 Hours Pharmacy - ABC VED AnalysisStudy of Drug Expenditure at RMMCH 24 Hours Pharmacy - ABC VED Analysis
Study of Drug Expenditure at RMMCH 24 Hours Pharmacy - ABC VED AnalysisChathreian S R
 
EuroBioForum 2013 - Day 1 | Katherine Payne
 EuroBioForum 2013 - Day 1 | Katherine Payne EuroBioForum 2013 - Day 1 | Katherine Payne
EuroBioForum 2013 - Day 1 | Katherine PayneEuroBioForum
 
Financial Protection and Improved Access to Health Care: A Spotlight on Pharm...
Financial Protection and Improved Access to Health Care: A Spotlight on Pharm...Financial Protection and Improved Access to Health Care: A Spotlight on Pharm...
Financial Protection and Improved Access to Health Care: A Spotlight on Pharm...HFG Project
 
Clinical Pathways
Clinical PathwaysClinical Pathways
Clinical Pathwayspradhasrini
 
Rolf Panel Ross Degnan
Rolf Panel Ross DegnanRolf Panel Ross Degnan
Rolf Panel Ross DegnanIDS
 
Pharmacy Orientation.pdf
Pharmacy Orientation.pdfPharmacy Orientation.pdf
Pharmacy Orientation.pdfHarisSaeedM03
 

Similar to Ward pharmacist economical assessment and actions, management tools , innovative technologies ,dose unit systems , pharmaceutical care , clinical pharmacy 2016 n.52 m .luisetto (20)

Pharmacoeconomics5-WPS Office.pdf
Pharmacoeconomics5-WPS Office.pdfPharmacoeconomics5-WPS Office.pdf
Pharmacoeconomics5-WPS Office.pdf
 
PHARMACOECONOMICS.pptx
PHARMACOECONOMICS.pptxPHARMACOECONOMICS.pptx
PHARMACOECONOMICS.pptx
 
Pharmacoeconomics pptx
Pharmacoeconomics pptxPharmacoeconomics pptx
Pharmacoeconomics pptx
 
Pharmacy Director Example
Pharmacy Director ExamplePharmacy Director Example
Pharmacy Director Example
 
Luisetto m logistics ict systems and clinical pharmaceutical care strategies...
Luisetto m  logistics ict systems and clinical pharmaceutical care strategies...Luisetto m  logistics ict systems and clinical pharmaceutical care strategies...
Luisetto m logistics ict systems and clinical pharmaceutical care strategies...
 
Cost cutting in hospitals
Cost cutting in hospitalsCost cutting in hospitals
Cost cutting in hospitals
 
PMY 6110_1-6-Pharmaceutical Care Evaluation.pdf
PMY 6110_1-6-Pharmaceutical Care Evaluation.pdfPMY 6110_1-6-Pharmaceutical Care Evaluation.pdf
PMY 6110_1-6-Pharmaceutical Care Evaluation.pdf
 
ASHP guidelines minimum standard for pharmacies in hospital N.59
ASHP guidelines minimum standard for pharmacies in hospital N.59ASHP guidelines minimum standard for pharmacies in hospital N.59
ASHP guidelines minimum standard for pharmacies in hospital N.59
 
Health products and technologies Dr. Julius Ogato, Ministry of Health. Head...
Health products and technologies   Dr. Julius Ogato, Ministry of Health. Head...Health products and technologies   Dr. Julius Ogato, Ministry of Health. Head...
Health products and technologies Dr. Julius Ogato, Ministry of Health. Head...
 
Research article a new #management healthcare systems to efficiently reduce h...
Research article a new #management healthcare systems to efficiently reduce h...Research article a new #management healthcare systems to efficiently reduce h...
Research article a new #management healthcare systems to efficiently reduce h...
 
ASHP Standard for pharmacy supportive personnel
ASHP Standard for pharmacy supportive personnelASHP Standard for pharmacy supportive personnel
ASHP Standard for pharmacy supportive personnel
 
Study of Drug Expenditure at RMMCH 24 Hours Pharmacy - ABC VED Analysis
Study of Drug Expenditure at RMMCH 24 Hours Pharmacy - ABC VED AnalysisStudy of Drug Expenditure at RMMCH 24 Hours Pharmacy - ABC VED Analysis
Study of Drug Expenditure at RMMCH 24 Hours Pharmacy - ABC VED Analysis
 
Ward pharmacy documenting activities 2014 N.50
Ward pharmacy documenting activities 2014 N.50Ward pharmacy documenting activities 2014 N.50
Ward pharmacy documenting activities 2014 N.50
 
EuroBioForum 2013 - Day 1 | Katherine Payne
 EuroBioForum 2013 - Day 1 | Katherine Payne EuroBioForum 2013 - Day 1 | Katherine Payne
EuroBioForum 2013 - Day 1 | Katherine Payne
 
Financial Protection and Improved Access to Health Care: A Spotlight on Pharm...
Financial Protection and Improved Access to Health Care: A Spotlight on Pharm...Financial Protection and Improved Access to Health Care: A Spotlight on Pharm...
Financial Protection and Improved Access to Health Care: A Spotlight on Pharm...
 
DUR Lecture - II (1).pptx
DUR Lecture - II (1).pptxDUR Lecture - II (1).pptx
DUR Lecture - II (1).pptx
 
Clinical Pathways
Clinical PathwaysClinical Pathways
Clinical Pathways
 
Ashp statement on pharmacy service to the emergency departement N.61
Ashp  statement on pharmacy service to the emergency departement N.61Ashp  statement on pharmacy service to the emergency departement N.61
Ashp statement on pharmacy service to the emergency departement N.61
 
Rolf Panel Ross Degnan
Rolf Panel Ross DegnanRolf Panel Ross Degnan
Rolf Panel Ross Degnan
 
Pharmacy Orientation.pdf
Pharmacy Orientation.pdfPharmacy Orientation.pdf
Pharmacy Orientation.pdf
 

More from M. Luisetto Pharm.D.Spec. Pharmacology

Acceptance letter 25052 (1)-2 SUDDEN CARDIAC DEATHS BEFORE - AFTER COVID -19 ...
Acceptance letter 25052 (1)-2 SUDDEN CARDIAC DEATHS BEFORE - AFTER COVID -19 ...Acceptance letter 25052 (1)-2 SUDDEN CARDIAC DEATHS BEFORE - AFTER COVID -19 ...
Acceptance letter 25052 (1)-2 SUDDEN CARDIAC DEATHS BEFORE - AFTER COVID -19 ...M. Luisetto Pharm.D.Spec. Pharmacology
 
ICRJ-2-1071 Monoliths in the mRNA Vaccine Purification Process the Silica Res...
ICRJ-2-1071 Monoliths in the mRNA Vaccine Purification Process the Silica Res...ICRJ-2-1071 Monoliths in the mRNA Vaccine Purification Process the Silica Res...
ICRJ-2-1071 Monoliths in the mRNA Vaccine Purification Process the Silica Res...M. Luisetto Pharm.D.Spec. Pharmacology
 
Current Research in Vaccines ACCEPTATION LETTER m R.N.A. PURIFICATIONS PROCES...
Current Research in Vaccines ACCEPTATION LETTER m R.N.A. PURIFICATIONS PROCES...Current Research in Vaccines ACCEPTATION LETTER m R.N.A. PURIFICATIONS PROCES...
Current Research in Vaccines ACCEPTATION LETTER m R.N.A. PURIFICATIONS PROCES...M. Luisetto Pharm.D.Spec. Pharmacology
 
Graphene Derivates Carbon Products and Separation Properties : the M R.N.A. P...
Graphene Derivates Carbon Products and Separation Properties : the M R.N.A. P...Graphene Derivates Carbon Products and Separation Properties : the M R.N.A. P...
Graphene Derivates Carbon Products and Separation Properties : the M R.N.A. P...M. Luisetto Pharm.D.Spec. Pharmacology
 
m R.N.A. Purifications Process: Affinity Chromato-Graphy, Magnetic Beads and ...
m R.N.A. Purifications Process: Affinity Chromato-Graphy, Magnetic Beads and ...m R.N.A. Purifications Process: Affinity Chromato-Graphy, Magnetic Beads and ...
m R.N.A. Purifications Process: Affinity Chromato-Graphy, Magnetic Beads and ...M. Luisetto Pharm.D.Spec. Pharmacology
 
JOURNAL OF FORENSIC PATHOLOGY ARTICLE IN PRESS LUISETTO ET AL 2022.docx
JOURNAL OF FORENSIC PATHOLOGY ARTICLE IN PRESS LUISETTO ET AL 2022.docxJOURNAL OF FORENSIC PATHOLOGY ARTICLE IN PRESS LUISETTO ET AL 2022.docx
JOURNAL OF FORENSIC PATHOLOGY ARTICLE IN PRESS LUISETTO ET AL 2022.docxM. Luisetto Pharm.D.Spec. Pharmacology
 
Acceptance letter j. of forensic research OPAST - White paper on Covid- 19 a...
Acceptance letter j. of forensic research OPAST - White paper on  Covid- 19 a...Acceptance letter j. of forensic research OPAST - White paper on  Covid- 19 a...
Acceptance letter j. of forensic research OPAST - White paper on Covid- 19 a...M. Luisetto Pharm.D.Spec. Pharmacology
 
Raman (Rs) Spettroscopy for Biopharmaceutical Quality Control and Pat Raw Mat...
Raman (Rs) Spettroscopy for Biopharmaceutical Quality Control and Pat Raw Mat...Raman (Rs) Spettroscopy for Biopharmaceutical Quality Control and Pat Raw Mat...
Raman (Rs) Spettroscopy for Biopharmaceutical Quality Control and Pat Raw Mat...M. Luisetto Pharm.D.Spec. Pharmacology
 
WHITE PAPER - m RNA vaccine production Quality control- regulatory and toxic...
WHITE PAPER - m RNA vaccine production Quality control-  regulatory and toxic...WHITE PAPER - m RNA vaccine production Quality control-  regulatory and toxic...
WHITE PAPER - m RNA vaccine production Quality control- regulatory and toxic...M. Luisetto Pharm.D.Spec. Pharmacology
 
SWJPS-Graphene and Derivates Physico-Chemical and Toxicology Properties in th...
SWJPS-Graphene and Derivates Physico-Chemical and Toxicology Properties in th...SWJPS-Graphene and Derivates Physico-Chemical and Toxicology Properties in th...
SWJPS-Graphene and Derivates Physico-Chemical and Toxicology Properties in th...M. Luisetto Pharm.D.Spec. Pharmacology
 
MENTAL ENERGY cover image by ALESSANDRA FALEGGI-Authors luisetto M et al 202...
MENTAL ENERGY cover image by ALESSANDRA FALEGGI-Authors luisetto M et  al 202...MENTAL ENERGY cover image by ALESSANDRA FALEGGI-Authors luisetto M et  al 202...
MENTAL ENERGY cover image by ALESSANDRA FALEGGI-Authors luisetto M et al 202...M. Luisetto Pharm.D.Spec. Pharmacology
 
ACCEPTATION LETTER SWJPS Review comment Form (swjps-1-107) Graphene and Deri...
ACCEPTATION LETTER SWJPS Review  comment Form (swjps-1-107) Graphene and Deri...ACCEPTATION LETTER SWJPS Review  comment Form (swjps-1-107) Graphene and Deri...
ACCEPTATION LETTER SWJPS Review comment Form (swjps-1-107) Graphene and Deri...M. Luisetto Pharm.D.Spec. Pharmacology
 
IMA 2022 Marijnskaya certificate GRAPHENE and DERIVATES chemico -physical ...
IMA  2022 Marijnskaya certificate GRAPHENE and  DERIVATES  chemico -physical ...IMA  2022 Marijnskaya certificate GRAPHENE and  DERIVATES  chemico -physical ...
IMA 2022 Marijnskaya certificate GRAPHENE and DERIVATES chemico -physical ...M. Luisetto Pharm.D.Spec. Pharmacology
 
EDITORIAL GRAPHENE and DERIVATES CHEMICO-PHYSICAL AND TOXICOLOGICAL PROPERT...
EDITORIAL  GRAPHENE and DERIVATES  CHEMICO-PHYSICAL AND TOXICOLOGICAL PROPERT...EDITORIAL  GRAPHENE and DERIVATES  CHEMICO-PHYSICAL AND TOXICOLOGICAL PROPERT...
EDITORIAL GRAPHENE and DERIVATES CHEMICO-PHYSICAL AND TOXICOLOGICAL PROPERT...M. Luisetto Pharm.D.Spec. Pharmacology
 
Pdf Book -GRAPHENE and DERIVATES PHYSICO- CHEMICAL AND TOXICOLOGY properti...
Pdf Book -GRAPHENE and  DERIVATES  PHYSICO- CHEMICAL  AND TOXICOLOGY properti...Pdf Book -GRAPHENE and  DERIVATES  PHYSICO- CHEMICAL  AND TOXICOLOGY properti...
Pdf Book -GRAPHENE and DERIVATES PHYSICO- CHEMICAL AND TOXICOLOGY properti...M. Luisetto Pharm.D.Spec. Pharmacology
 
Sars-cov2 Spike protein and derivates toxicology :fertility and teratogen eva...
Sars-cov2 Spike protein and derivates toxicology :fertility and teratogen eva...Sars-cov2 Spike protein and derivates toxicology :fertility and teratogen eva...
Sars-cov2 Spike protein and derivates toxicology :fertility and teratogen eva...M. Luisetto Pharm.D.Spec. Pharmacology
 
Luisetto M ND agosto 2022 estratto in lingua italiana pubb. 05-08-2022 GRA...
Luisetto M  ND agosto 2022 estratto in lingua italiana pubb. 05-08-2022   GRA...Luisetto M  ND agosto 2022 estratto in lingua italiana pubb. 05-08-2022   GRA...
Luisetto M ND agosto 2022 estratto in lingua italiana pubb. 05-08-2022 GRA...M. Luisetto Pharm.D.Spec. Pharmacology
 

More from M. Luisetto Pharm.D.Spec. Pharmacology (20)

Acceptance letter 25052 (1)-2 SUDDEN CARDIAC DEATHS BEFORE - AFTER COVID -19 ...
Acceptance letter 25052 (1)-2 SUDDEN CARDIAC DEATHS BEFORE - AFTER COVID -19 ...Acceptance letter 25052 (1)-2 SUDDEN CARDIAC DEATHS BEFORE - AFTER COVID -19 ...
Acceptance letter 25052 (1)-2 SUDDEN CARDIAC DEATHS BEFORE - AFTER COVID -19 ...
 
Teoria del libro PLUS IMAGO- PHILOSOPHIA ET SCIENTIA
Teoria del libro PLUS IMAGO- PHILOSOPHIA ET SCIENTIA  Teoria del libro PLUS IMAGO- PHILOSOPHIA ET SCIENTIA
Teoria del libro PLUS IMAGO- PHILOSOPHIA ET SCIENTIA
 
Mauro Luisetto Abstract Acceptance Letter.pdf
Mauro Luisetto Abstract Acceptance Letter.pdfMauro Luisetto Abstract Acceptance Letter.pdf
Mauro Luisetto Abstract Acceptance Letter.pdf
 
Teoria del libro PLUS IMAGO- PHILOSOPHIA ET SCIENTIA.pdf
Teoria del libro PLUS IMAGO- PHILOSOPHIA ET SCIENTIA.pdfTeoria del libro PLUS IMAGO- PHILOSOPHIA ET SCIENTIA.pdf
Teoria del libro PLUS IMAGO- PHILOSOPHIA ET SCIENTIA.pdf
 
ICRJ-2-1071 Monoliths in the mRNA Vaccine Purification Process the Silica Res...
ICRJ-2-1071 Monoliths in the mRNA Vaccine Purification Process the Silica Res...ICRJ-2-1071 Monoliths in the mRNA Vaccine Purification Process the Silica Res...
ICRJ-2-1071 Monoliths in the mRNA Vaccine Purification Process the Silica Res...
 
Current Research in Vaccines ACCEPTATION LETTER m R.N.A. PURIFICATIONS PROCES...
Current Research in Vaccines ACCEPTATION LETTER m R.N.A. PURIFICATIONS PROCES...Current Research in Vaccines ACCEPTATION LETTER m R.N.A. PURIFICATIONS PROCES...
Current Research in Vaccines ACCEPTATION LETTER m R.N.A. PURIFICATIONS PROCES...
 
Graphene Derivates Carbon Products and Separation Properties : the M R.N.A. P...
Graphene Derivates Carbon Products and Separation Properties : the M R.N.A. P...Graphene Derivates Carbon Products and Separation Properties : the M R.N.A. P...
Graphene Derivates Carbon Products and Separation Properties : the M R.N.A. P...
 
m R.N.A. Purifications Process: Affinity Chromato-Graphy, Magnetic Beads and ...
m R.N.A. Purifications Process: Affinity Chromato-Graphy, Magnetic Beads and ...m R.N.A. Purifications Process: Affinity Chromato-Graphy, Magnetic Beads and ...
m R.N.A. Purifications Process: Affinity Chromato-Graphy, Magnetic Beads and ...
 
JOURNAL OF FORENSIC PATHOLOGY ARTICLE IN PRESS LUISETTO ET AL 2022.docx
JOURNAL OF FORENSIC PATHOLOGY ARTICLE IN PRESS LUISETTO ET AL 2022.docxJOURNAL OF FORENSIC PATHOLOGY ARTICLE IN PRESS LUISETTO ET AL 2022.docx
JOURNAL OF FORENSIC PATHOLOGY ARTICLE IN PRESS LUISETTO ET AL 2022.docx
 
Acceptance letter j. of forensic research OPAST - White paper on Covid- 19 a...
Acceptance letter j. of forensic research OPAST - White paper on  Covid- 19 a...Acceptance letter j. of forensic research OPAST - White paper on  Covid- 19 a...
Acceptance letter j. of forensic research OPAST - White paper on Covid- 19 a...
 
Raman (Rs) Spettroscopy for Biopharmaceutical Quality Control and Pat Raw Mat...
Raman (Rs) Spettroscopy for Biopharmaceutical Quality Control and Pat Raw Mat...Raman (Rs) Spettroscopy for Biopharmaceutical Quality Control and Pat Raw Mat...
Raman (Rs) Spettroscopy for Biopharmaceutical Quality Control and Pat Raw Mat...
 
WHITE PAPER - m RNA vaccine production Quality control- regulatory and toxic...
WHITE PAPER - m RNA vaccine production Quality control-  regulatory and toxic...WHITE PAPER - m RNA vaccine production Quality control-  regulatory and toxic...
WHITE PAPER - m RNA vaccine production Quality control- regulatory and toxic...
 
SWJPS-Graphene and Derivates Physico-Chemical and Toxicology Properties in th...
SWJPS-Graphene and Derivates Physico-Chemical and Toxicology Properties in th...SWJPS-Graphene and Derivates Physico-Chemical and Toxicology Properties in th...
SWJPS-Graphene and Derivates Physico-Chemical and Toxicology Properties in th...
 
MENTAL ENERGY cover image by ALESSANDRA FALEGGI-Authors luisetto M et al 202...
MENTAL ENERGY cover image by ALESSANDRA FALEGGI-Authors luisetto M et  al 202...MENTAL ENERGY cover image by ALESSANDRA FALEGGI-Authors luisetto M et  al 202...
MENTAL ENERGY cover image by ALESSANDRA FALEGGI-Authors luisetto M et al 202...
 
ACCEPTATION LETTER SWJPS Review comment Form (swjps-1-107) Graphene and Deri...
ACCEPTATION LETTER SWJPS Review  comment Form (swjps-1-107) Graphene and Deri...ACCEPTATION LETTER SWJPS Review  comment Form (swjps-1-107) Graphene and Deri...
ACCEPTATION LETTER SWJPS Review comment Form (swjps-1-107) Graphene and Deri...
 
IMA 2022 Marijnskaya certificate GRAPHENE and DERIVATES chemico -physical ...
IMA  2022 Marijnskaya certificate GRAPHENE and  DERIVATES  chemico -physical ...IMA  2022 Marijnskaya certificate GRAPHENE and  DERIVATES  chemico -physical ...
IMA 2022 Marijnskaya certificate GRAPHENE and DERIVATES chemico -physical ...
 
EDITORIAL GRAPHENE and DERIVATES CHEMICO-PHYSICAL AND TOXICOLOGICAL PROPERT...
EDITORIAL  GRAPHENE and DERIVATES  CHEMICO-PHYSICAL AND TOXICOLOGICAL PROPERT...EDITORIAL  GRAPHENE and DERIVATES  CHEMICO-PHYSICAL AND TOXICOLOGICAL PROPERT...
EDITORIAL GRAPHENE and DERIVATES CHEMICO-PHYSICAL AND TOXICOLOGICAL PROPERT...
 
Pdf Book -GRAPHENE and DERIVATES PHYSICO- CHEMICAL AND TOXICOLOGY properti...
Pdf Book -GRAPHENE and  DERIVATES  PHYSICO- CHEMICAL  AND TOXICOLOGY properti...Pdf Book -GRAPHENE and  DERIVATES  PHYSICO- CHEMICAL  AND TOXICOLOGY properti...
Pdf Book -GRAPHENE and DERIVATES PHYSICO- CHEMICAL AND TOXICOLOGY properti...
 
Sars-cov2 Spike protein and derivates toxicology :fertility and teratogen eva...
Sars-cov2 Spike protein and derivates toxicology :fertility and teratogen eva...Sars-cov2 Spike protein and derivates toxicology :fertility and teratogen eva...
Sars-cov2 Spike protein and derivates toxicology :fertility and teratogen eva...
 
Luisetto M ND agosto 2022 estratto in lingua italiana pubb. 05-08-2022 GRA...
Luisetto M  ND agosto 2022 estratto in lingua italiana pubb. 05-08-2022   GRA...Luisetto M  ND agosto 2022 estratto in lingua italiana pubb. 05-08-2022   GRA...
Luisetto M ND agosto 2022 estratto in lingua italiana pubb. 05-08-2022 GRA...
 

Ward pharmacist economical assessment and actions, management tools , innovative technologies ,dose unit systems , pharmaceutical care , clinical pharmacy 2016 n.52 m .luisetto

  • 1. ward pharmacist economical assessement and actions ASHP Guidelines:clinical pharmacy service,in which pharmacist provide direct patient care are important foundation for succesful medication utilization management program focused on managing drug cost tools and approach Health economics, pharmacoeconomy, healthcare management resource with rational allocation cost analisys -cost- benefit, cost efficacy, cost effectiveness ( anayitical way, cost center ) appropriateness regulatory ( central reimbursement classification, limitation note etc ) management budget control systematic approach prioritizing management startegies drug budgeting( formulary/non formulary) budget impact analisys cost containment targets definied medication cost management project selection ( ex. high expensive or high budget impact therapy ) benchmarking data analysis formulary management,drug restriction policy dose unit systems ( ex. to reduce waste), ICT collaborative working group ( team , central pharmacy , hospital management) ward clinical pharmacy service,clinical pharmacist with advanced training dedicated to cost management project monitoring
  • 2. buying strategy use of Evidence based criteria, biomedical literature use generic drug intensive use drug day ( ex to reduce waste ) iv os switch ( to reduce cost ) iv waste reduction comunication skills comitee partecipation ( departmental) updating